CYLEMBIO Trademark
Trademark Overview
On Tuesday, February 6, 2024, a trademark application was filed for CYLEMBIO with the United States Patent and Trademark Office. The USPTO has given the CYLEMBIO trademark a serial number of 98394978. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 17, 2024. This trademark is owned by IO Biotech ApS. The CYLEMBIO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines
General Information
| Serial Number | 98394978 |
| Word Mark | CYLEMBIO |
| Filing Date | Tuesday, February 6, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, December 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 17, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the stylized wording CYLEMBIO with a circle made up of ten circles of varying sizes in a circular pattern above the letter "I". |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 14, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | IO Biotech ApS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Copenhagen N DK-2200
DK |
| Party Name | IO Biotech ApS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Copenhagen N DK-2200
DK |
Trademark Events
| Event Date | Event Description |
| Friday, February 9, 2024 | NEW APPLICATION ENTERED |
| Friday, March 15, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, September 11, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 11, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 11, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, October 7, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, October 17, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Thursday, March 14, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 29, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, December 11, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 17, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 17, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
